Carmen Purdel elected as new chair of the Committee for Herbal Medicinal Products
Carmen Purdel will begin her three-year mandate in March 2026.
NewsHumanHerbalCorporate
At its January meeting, EMA’s Committee for Herbal Medicinal Products (HMPC) elected Carmen Purdel as its new chair, for a three-year mandate starting on 2 March 2026.
Carmen Purdel is a quality assessor at the National Agency for Medicines and Medical Devices in Romania and an associate professor at the Department of Toxicology at the University of Medicine and Pharmacy in Bucharest, Romania.
She has been part of the Committee since 2011, initially as an alternate and subsequently as a member. Professor Purdel will replace Emiel van Galen of the Botanicals and Novel Foods at the Medicines Evaluation Board (CBG-MEB), who will retire as chair having served a maximum two three-year mandates.
“The HMPC, through its high-quality scientific recommendations, plays a vital role in harmonising the regulation of herbal medicinal products and substance in the EU. A key priority is to explore new initiatives for the structured use of real-world data which offer significant opportunities to support our work in the assessment of herbal substances and preparations.
As chair, I am committed to foster the exchange of collective expertise within the network providing accessible and transparent communication on traditional herbal medicines products to ensure their safe and informed use on the EU market."
The HMPC is the committee responsible for compiling and assessing scientific data on herbal substances, preparations and combinations, to support the harmonisation of the European market. HMPC prepares EMA’s opinions on herbal substances and preparations, along with information on recommended uses and safe conditions. Thus, national competent authorities are able to refer to one unique set of information on a herbal substance or preparation when evaluating marketing applications for herbal medicines.